Real-time continuous glucose monitoring vs. self-monitoring of blood glucose: cost-utility in South Korean type 2 diabetes patients on intensive insulin.
Ji Yoon KimSabrina IlhamHamza AlshannaqRichard F PollockWaqas AhmedGregory J NormanSang-Man JinJae Hyeon KimPublished in: Journal of medical economics (2024)
For individuals with T2D managed by intensive insulin therapy in South Korea, rt-CGM is cost-effective relative to SMBG.